We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-3.25%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$6.01B
AUM Growth
+$262M
Cap. Flow
-$162M
Cap. Flow %
-2.7%
Top 10 Hldgs %
51.52%
Holding
592
New
224
Increased
125
Reduced
42
Closed
159

Top Buys

Rank Stock Value
1
WAY
Waystar Holding Corp
WAY
+$107M
2
GILD icon
Gilead Sciences
GILD
+$99.5M
3
CVS icon
CVS Health
CVS
+$61M
4
BAX icon
Baxter International
BAX
+$57.9M
5
CGEM icon
Cullinan Oncology
CGEM
+$45.6M

Top Sells

Rank Stock Value
1
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
+$136M
2
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$80.7M
3
SWTX
SpringWorks Therapeutics
SWTX
+$63.2M
4
OSCR icon
Oscar Health
OSCR
+$44.4M
5
VKTX icon
Viking Therapeutics
VKTX
+$38M

Sector Composition

Rank Sector Weight
1 Healthcare 83.29%
2 Industrials 0.69%
3 Technology 0.57%
4 Financials 0.44%
5 Consumer Discretionary 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KDP icon
501
Keurig Dr Pepper
KDP
$41B
– –
-6,531
Closed -$200K
KELYA icon
502
Kelly Services Class A
KELYA
$545M
– –
-15,063
Closed -$377K
LAB icon
503
Standard BioTools
LAB
$303M
– –
-78,090
Closed -$212K
LDOS icon
504
Leidos
LDOS
$14.5B
– –
-2,758
Closed -$362K
LMAT icon
505
LeMaitre Vascular
LMAT
$2.26B
– –
-6,770
Closed -$449K
LQDA icon
506
Liquidia Corp
LQDA
$7.51B
– –
-18,429
Closed -$272K
MAIN icon
507
Main Street Capital
MAIN
$5B
– –
-9,556
Closed -$452K
MARA icon
508
Marathon Digital Holdings
MARA
$4.49B
– –
-14,719
Closed -$332K
MBI icon
509
MBIA
MBI
$282M
– –
-23,856
Closed -$161K
MET icon
510
MetLife
MET
$61.2B
– –
-2,947
Closed -$218K
METC icon
511
Ramaco Resources Class A
METC
$664M
– –
-19,642
Closed -$320K
MKSI icon
512
MKS Inc
MKSI
$21.3B
– –
-2,326
Closed -$309K
MMM icon
513
3M
MMM
$91.9B
– –
-5,590
Closed -$496K
MPLX icon
514
MPLX
MPLX
$59.2B
– –
-10,892
Closed -$453K
MRNA icon
515
Moderna
MRNA
$22.1B
– –
-2,337
Closed -$249K
MRSN
516
DELISTED
Mersana Therapeutics
MRSN
– –
-2,299
Closed -$258K
MS icon
517
Morgan Stanley
MS
$337B
– –
-2,734
Closed -$257K
MSA icon
518
Mine Safety
MSA
$6.78B
– –
-2,272
Closed -$440K
MSI icon
519
Motorola Solutions
MSI
$70.3B
– –
-580
Closed -$206K
MTD icon
520
Mettler-Toledo International
MTD
$27B
– –
-177
Closed -$236K
NABL icon
521
N-able
NABL
$823M
– –
-57,956
Closed -$757K
NGL icon
522
NGL Energy Partners
NGL
$1.87B
– –
-42,830
Closed -$247K
NTRS icon
523
Northern Trust
NTRS
$22.4B
– –
-4,582
Closed -$407K
NYT icon
524
New York Times
NYT
$11.7B
– –
-7,964
Closed -$344K
OCUL icon
525
Ocular Therapeutix
OCUL
$1.89B
– –
-31,852
Closed -$290K
19 20
21
22 23

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q2 2024 Portfolio in Review

As of Q2 2024, Deerfield Management held 592 positions worth $6.01B, up 4.6% from $5.75B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Deerfield Management's Q2 2024 filing shows 224 new, 125 increased, 42 reduced and 159 closed positions. Its largest new stake was Waystar Holding Corp: 4,952,004 shares worth $106M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $136M.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 89% a quarter earlier, followed by Industrials and Technology.

  • Deerfield Management's largest Q2 2024 buy was Waystar Holding Corp: 4,952,004 shares worth $106M.
  • Deerfield Management added most to Baxter International in Q2 2024, an estimated $57.9M increase.
  • Deerfield Management's biggest Q2 2024 reduction was Oscar Health, cutting an estimated $44.4M.
  • Deerfield Management fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $136M.
  • Deerfield Management's ten largest holdings make up 52% of its $6.01B portfolio in Q2 2024.
  • Deerfield Management opened 224 new positions and closed 159 in Q2 2024.
  • Deerfield Management's portfolio value rose 4.6% quarter-over-quarter to $6.01B.

Based on Deerfield Management's 13F filing for Q2 2024, filed 14 Aug 2024.